Nplate 500 MCG vials
Ended Awarded
- Contract number
- SPE2DB25FKEKS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,697
Award facts
- Contract value 100% obligated
- $6,697.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,697.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 500 micrograms vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. This award was made without a set-aside designation, allowing the vendor to compete on an unrestricted basis. Nplate is a thrombopoietin receptor agonist used to treat thrombocytopenia, and this delivery order represents a specific fulfillment under DMS Pharmaceutical Group's larger procurement relationship with the government.
This delivery order is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, established under the SPE2DB program, authorizes the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products supporting medical supply requirements across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to consistently secure contracts for branded and generic prescription drugs, biologics, vaccines, and medical consumables distributed to military and federal healthcare systems nationally and internationally.
Quick answers
Who was awarded contract SPE2DB25FKEKS?
SPE2DB25FKEKS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FKEKS worth?
The government has obligated $6,697 on SPE2DB25FKEKS.
Is contract SPE2DB25FKEKS an order under another contract?
Yes. SPE2DB25FKEKS is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEKS competed?
The extent of competition for SPE2DB25FKEKS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award